Study of Safety and Efficacy Of Ertugliflozin (PF-04971729, MK-8835) In Participants With Type 2 Diabetes And Hypertension (MK-8835-042)
Clinical trial NCT01096667 · COMPLETED
Trial details
- NCT number
- NCT01096667
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-17
- Primary completion
- 2011-02-09
- Enrollment
- 194
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.